Therefore, this study aims to investigate the abilities of GCF biomarker levels of MMP8, TIMP1, RANK, RANKL, and OPG to differentiate between SAP and AAP in patients with AP. This evidence concerns the gene TIMP1 and alkaline phosphatase measurement.